Which has the lower trailing P/E, ELV or GSK?

GSK has the lower trailing P/E: ELV trades at 17.60 and GSK at 15.57. P/E is one valuation measure and does not by itself establish which business is cheaper.

Which has grown faster, ELV or GSK?

Over the past five years, ELV grew revenue faster — ELV at a 9.25% CAGR versus GSK at 1.38%.

Does ELV or GSK pay a bigger dividend?

ELV yields 1.64% and GSK yields 3.78% based on trailing dividends and the latest price.

Is ELV or GSK more profitable?

GSK runs the higher net margin — ELV at 2.47% versus GSK at 14.52%.

How have ELV and GSK total returns compared?

Over the past 10 years, ELV delivered 14.24% and GSK delivered 6.11% annualized total return. Past performance doesn't predict future results.

Elevance Health Inc. (ELV) vs GSK plc (GSK)

A side-by-side comparison of Elevance Health Inc. and GSK plc across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of September 13, 2026. Differences are shown without an overall score or investment verdict.

ELV

Elevance Health Inc.

$85.90B

$396.09HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

GSK

GSK plc

$98.65B

$49.24HealthcareDelayed quote: Sep 25, 2026, 4:00 PM EDT

Total return — ELV vs GSK

growth of $100 · dividends reinvested · last 10y

ELV +286.4% (+14.5%/yr)GSK +76.2% (+5.8%/yr)ELV compounded faster over this window

ELV GSK

ELV vs GSK: by the numbers

•GSK is the larger company ($98.65B vs $85.90B market cap).
•GSK trades at the lower trailing earnings multiple (15.57 vs 17.60 P/E), one valuation lens rather than an overall verdict.
•GSK converts more revenue to profit (14.52% vs 2.47% net margin).
•ELV grew revenue faster over the past five years (9.25% vs 1.38% CAGR).
•GSK pays the higher dividend yield (3.78% vs 1.64%).

Metrics side by side

Valuation

Metric	ELV	GSK
P/E ratio	17.60	15.57
Forward P/E	14.59	N/A
P/S ratio	0.43	2.23
P/B ratio	1.91	4.24
EV / EBITDA	13.21	7.97
FCF yield	7.32%	9.46%

Profitability

Metric	ELV	GSK
Gross margin	25.56%	72.71%
Operating margin	3.51%	20.72%
Net margin	2.47%	14.52%
ROE	11.06%	27.67%
ROIC	6.34%	13.95%

Dividends

Metric	ELV	GSK
Dividend yield	1.64%	3.78%
Payout ratio	30.49%	57.45%

Growth (annualized)

Metric	ELV	GSK
Revenue CAGR (5Y)	9.25%	1.38%
EPS CAGR (5Y)	6.67%	-0.71%
FCF CAGR (5Y)	-19.97%	-2.45%
Total return CAGR (5Y)	4.73%	8.21%

Frequently asked

Which has the lower trailing P/E, ELV or GSK?: GSK has the lower trailing P/E: ELV trades at 17.60 and GSK at 15.57. P/E is one valuation measure and does not by itself establish which business is cheaper.
Which has grown faster, ELV or GSK?: Over the past five years, ELV grew revenue faster — ELV at a 9.25% CAGR versus GSK at 1.38%.
Does ELV or GSK pay a bigger dividend?: ELV yields 1.64% and GSK yields 3.78% based on trailing dividends and the latest price.
Is ELV or GSK more profitable?: GSK runs the higher net margin — ELV at 2.47% versus GSK at 14.52%.
How have ELV and GSK total returns compared?: Over the past 10 years, ELV delivered 14.24% and GSK delivered 6.11% annualized total return. Past performance doesn't predict future results.

Go deeper

Full ELV analysis Full GSK analysis Interactive comparison tool

Dig into the metrics

Elevance Health P/E ratio GSK P/E ratio Elevance Health dividend yield GSK dividend yield Elevance Health ROE GSK ROE Elevance Health operating margin GSK operating margin Elevance Health revenue growth GSK revenue growth Elevance Health free cash flow GSK free cash flow

Elevance Health & GSK appear in these rankings

Highest Dividend Yield Stocks Highest ROE Stocks Highest FCF Yield Stocks Highest 10-Year Total Return Stocks

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified September 13, 2026.